DEEPAKNTR · Chemicals
The board meets on 29 Oct 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,778 cr | ₹2,009 cr | ₹2,126 cr | ₹2,167 cr | ₹2,032 cr | ₹1,903 cr | ₹2,180 cr | ₹1,890 cr | ₹1,902 cr | ₹1,975 cr | ₹2,120 cr | ₹2,578 cr |
| YoY | — | — | — | +23% | +14% | −5% | +3% | −13% | −6% | +4% | −3% | +36% |
| EBITDA margin | 17.0% | 15.2% | 14.2% | 14.3% | 14.7% | 8.9% | 14.5% | 10.1% | 10.7% | 10.7% | 17.7% | 20.9% |
| Other income, % of PBT | 6% | 5% | 28% | 7% | 8% | 16% | 8% | 16% | 12% | −3% | 2% | 3% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 26% | 26% | 27% | 26% | 26% | 27% | 27% | 27% | 27% | 28% | 27% | 26% |
| Net profit | ₹205 cr | ₹202 cr | ₹254 cr | ₹203 cr | ₹194 cr | ₹98.0 cr | ₹202 cr | ₹112 cr | ₹119 cr | ₹100 cr | ₹220 cr | ₹345 cr |
| YoY | — | — | — | +35% | −5% | −51% | −20% | −45% | −39% | +2% | +9% | +208% |
| Core profit YoY | — | — | — | +51% | −7% | −56% | +2% | −49% | −41% | +25% | +15% | +249% |
| EPS | ₹15.04 | ₹14.81 | ₹18.61 | ₹14.85 | ₹14.24 | ₹7.19 | ₹14.84 | ₹8.23 | ₹8.70 | ₹7.32 | ₹16.11 | ₹25.30 |
| Flags | · | · | · | ✓ | ✓ | 1 | ✓ | 1 | 1 | ✓ | ✓ | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.